Press Release

AI-based drug development is becoming a game changer.

AI-based drug development is becoming a game changer. 더 읽기"

PharmCADD participated the special donation activity of Salvation Army

PharmCADD participated the special donation activity of Salvation Army 더 읽기"

PharmCADD will open Pharmulator ver. 2.5 and PharmVAC, AI-based drug discovery platforms during CES 2022.

PharmCADD will open Pharmulator ver. 2.5 and PharmVAC, AI-based drug discovery platforms during CES 2022. 더 읽기"

The love of neighbors from PharmCADD

The love of neighbors from PharmCADD 더 읽기"

“I am sure that our company can commercialize the mRNA vaccine which has less side effect than the vaccines of Moderna or Pfizer”, said Eyegene CTO.

“I am sure that our company can commercialize the mRNA vaccine which has less side effect than the vaccines of Moderna or Pfizer”, said Eyegene CTO. 더 읽기"

PharmCADD won a Patent Management Award from Ministry of Science and ICT.

PharmCADD won a Patent Management Award from Ministry of Science and ICT. 더 읽기"

Dr. Sangwook Wu, PharmCADD CEO, won the Minister of SMEs and Startups Award.

Dr. Sangwook Wu, PharmCADD CEO, won the Minister of SMEs and Startups Award. 더 읽기"

PharmCADD, advanced the AI platform ‘PharmVAC’ for vaccine development

PharmCADD, advanced the AI platform ‘PharmVAC’ for vaccine development 더 읽기"

Dr. Sangwook Wu, PhramCADD CEO, won Minister of Health and Welfare Awards, “Technology Commercialization Merit Awards”.

Dr. Sangwook Wu, PhramCADD CEO, won Minister of Health and Welfare Awards, “Technology Commercialization Merit Awards”. 더 읽기"

PharmCADD joined in Daily Partners Open Innovation 2021.

PharmCADD joined in Daily Partners Open Innovation 2021. 더 읽기"